The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding

Bioscience Reports

Volumn 33, Issue 5, 2013, Pages

  Pham, Chi L L ^a,b,c   Cappai, Roberto ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

synuclein; Dopamine; Lipid; Oligomer; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; MELANIN; MEMBRANE LIPID;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; HYDROGEN BOND; HYDROPHOBICITY; LIPID VESICLE; MEMBRANE BINDING; MEMBRANE PERMEABILITY; OLIGOMERIZATION;

ALPHA-SYNUCLEIN; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DOPAMINE; FLUORESCEINS; FLUORESCENT DYES; HUMANS; LIPOSOMES; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS;

EID: 84887124634     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20130092     Document Type: Article

References (49)

1. Ding, T. T., Lee, S. J., Rochet, J. C. and Lansbury, Jr, P. T. (2002) Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41, 10209-10217
2. Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B. and Kostka, M. (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 27, 9220-9232
3. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E. and Glabe, C. G. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366
4. Zhu, M., Li, J. and Fink, A. L. (2003) The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J. Biol. Chem. 278, 40186-40197
5. Volles, M. J. and Lansbury, P. T., Jr. (2002) Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry. 41, 4595-4602
6. Feng, L. R., Federoff, H. J., Vicini, S. and Maguire-Zeiss, K. A. (2010) Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. Eur. J. Neurosci. 32, 10-17
7. van Rooijen, B. D., Claessens, M. M. and Subramaniam, V. (2008) Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing. FEBS Lett. 582, 3788-3792
8. van Rooijen, B. D., Claessens, M. M. and Subramaniam, V. (2009) Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core. Biochim. Biophys. Acta 1788, 1271-1278
9. Bartels, T., Ahlstrom, L. S., Leftin, A., Kamp, F., Haass, C., Brown, M. F. and Beyer, K. (2010) The N-terminus of the intrinsically disordered protein alpha-synuclein triggers membrane binding and helix folding. Biophys. J. 99, 2116-2124
10. Ulmer, T. S. and Bax, A. (2005) Comparison of structure and dynamics of micelle-bound human alpha-synuclein and Parkinson disease variants. J. Biol. Chem. 280, 43179-43187
11. Chandra, S., Chen, X., Rizo, J., Jahn, R. and Sudhof, T. C. (2003) A broken alpha -helix in folded alpha-synuclein. J. Biol. Chem. 278, 15313-15318
12. Eliezer, D., Kutluay, E., Bussell, R., Jr. and Browne, G. (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061-1073
13. Davidson, W. S., Jonas, A., Clayton, D. F. and George, J. M. (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449
14. Middleton, E. R. and Rhoades, E. (2010) Effects of curvature and composition on alpha-synuclein binding to lipid vesicles. Biophys. J. 99, 2279-2288
15. Smith, D. P., Tew, D. J., Hill, A. F., Bottomley, S. P., Masters, C. L., Barnham, K. J. and Cappai, R. (2008) Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein. Biochemistry 47, 1425-1434
16. Narayanan, V. and Scarlata, S. (2001) Membrane binding and self-association of alpha-synucleins. Biochemistry 40, 9927-9934
17. McLean, P. J., Kawamata, H., Ribich, S. and Hyman, B. T. (2000) Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. J. Biol. Chem. 275, 8812-8816
18. Cole, N. B., Murphy, D. D., Grider, T., Rueter, S., Brasaemle, D. and Nussbaum, R. L. (2002) Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J. Biol. Chem. 277, 6344-6352
19. Lee, H. J., Choi, C. and Lee, S. J. (2002) Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277, 671-678
20. Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S., Anthony, M. D. and Edwards, R. H. (2004) Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 24, 6715-6723
21. Nakamura, K., Nemani, V. M., Wallender, E. K., Kaehlcke, K., Ott, M. and Edwards, R. H. (2008) Optical reporters for the conformation of alpha-synuclein reveal a specific interaction with mitochondria. J. Neurosci. 28, 12305-12317
22. Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G. and Anandatheerthavarada, H. K. (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089-9100
23. Banerjee, K., Sinha, M., Pham, C. L., Jana, S., Chanda, D., Cappai, R. and Chakrabarti, S. (2010) Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease. FEBS Lett. 584, 1571-1576
24. Gaugler, M. N., Genc, O., Bobela, W., Mohanna, S., Ardah, M. T., El-Agnaf, O. M., Cantoni, M., Bensadoun, J. C., Schneggenburger, R., Knott, G. W. et al. (2012) Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity. Acta Neuropath. 123, 653-669
25. Yavich, L., Jakala, P. and Tanila, H. (2006) Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. J. Neurochem. 99, 724-732
26. Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K. and Brundin, P. (2002) Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 277, 38884-38894
27. Zhu, M. and Fink, A. L. (2003) Lipid binding inhibits alpha-synuclein fibril formation. J. Biol. Chem. 278, 16873-16877
28. Perrin, R. J., Woods, W. S., Clayton, D. F. and George, J. M. (2001) Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem. 276, 41958-41962
29. De Franceschi, G., Frare, E., Pivato, M., Relini, A., Penco, A., Greggio, E., Bubacco, L., Fontana, A. and de Laureto, P. P. (2011) Structural and morphological characterization of aggregated species of alpha-synuclein induced by docosahexaenoic acid. J. Biol. Chem. 286, 22262-22274
30. Necula, M., Chirita, C. N. and Kuret, J. (2003) Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro. J. Biol. Chem. 278, 46674-46680
31. Reynolds, N. P., Soragni, A., Rabe, M., Verdes, D., Liverani, E., Handschin, S., Riek, R. and Seeger, S. (2011) Mechanism of membrane interaction and disruption by alpha-synuclein. J. Am. Chem. Soc. 133, 19366-19375
32. Comellas, G., Lemkau, L. R., Zhou, D. H., George, J. M. and Rienstra, C. M. (2012) Structural intermediates during alpha-synuclein fibrillogenesis on phospholipid vesicles. J. Am. Chem. Soc. 134, 5090-5099
33. Conway, K. A., Rochet, J. C., Bieganski, R. M. and Lansbury, P. T., Jr. (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294, 1346-1349
34. Cappai, R., Leck, S. L., Tew, D. J., Williamson, N. A., Smith, D. P., Galatis, D., Sharples, R. A., Curtain, C. C., Ali, F. E., Cherny, R. A. et al. (2005) Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J. 19, 1377-1379
35. Norris, E. H., Giasson, B. I., Hodara, R., Xu, S., Trojanowski, J. Q., Ischiropoulos, H. and Lee, V. M. (2005) Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations. J. Biol. Chem. 280, 21212-21219
36. Pham, C. L., Leong, S. L., Ali, F. E., Kenche, V. B., Hill, A. F., Gras, S. L., Barnham, K. J. and Cappai, R. (2009) Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner. J. Mol. Biol. 387, 771-785
37. Bisaglia, M., Tosatto, L., Munari, F., Tessari, I., de Laureto, P. P., Mammi, S. and Bubacco, L. (2010) Dopamine quinones interact with alpha-synuclein to form unstructured adducts. Biochem. Biophys. Res. Comm. 394, 424-428
38. Leong, S. L., Pham, C. L., Galatis, D., Fodero-Tavoletti, M. T., Perez, K., Hill, A. F., Masters, C. L., Ali, F. E., Barnham, K. J. and Cappai, R. (2009) Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation. Free Radic. Biol. Med. 46, 1328-1337
39. Rekas, A., Knott, R. B., Sokolova, A., Barnham, K. J., Perez, K. A., Masters, C. L., Drew, S. C., Cappai, R., Curtain, C. C. and Pham, C. L. (2010) The structure of dopamine induced alpha-synuclein oligomers. Eur. Biophys. J. 39, 1407-1419
40. Bussell, R. Jr. and Eliezer, D. (2003) A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J. Mol. Biol. 329, 763-778
41. Ulmer, T. S., Bax, A., Cole, N. B. and Nussbaum, R. L. (2005) Structure and dynamics of micelle-bound human alpha-synuclein. J. Biol. Chem. 280, 9595-9603
42. Ahmad, M. F., Ramakrishna, T., Raman, B. and Rao Ch, M. (2006) Fibrillogenic and non-fibrillogenic ensembles of SDS-bound human alpha-synuclein. J. Mol. Biol. 364, 1061-1072
43. Li, H. T., Lin, D. H., Luo, X. Y., Zhang, F., Ji, L. N., Du, H. N., Song, G. Q., Hu, J., Zhou, J. W. and Hu, H. Y. (2005) Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration. FEBS J. 272, 3661-3672
44. Mazzulli, J. R., Mishizen, A. J., Giasson, B. I., Lynch, D. R., Thomas, S. A., Nakashima, A., Nagatsu, T., Ota, A. and Ischiropoulos, H. (2006) Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J. Neurosci. 26, 10068-10078
45. Ito, S., Nakaso, K., Imamura, K., Takeshima, T. and Nakashima, K. (2010) Endogenous catecholamine enhances the dysfunction of unfolded protein response and alpha-synuclein oligomerization in PC12 cells overexpressing human alpha-synuclein. Neurosci. Res. 66, 124-130
46. Yamakawa, K., Izumi, Y., Takeuchi, H., Yamamoto, N., Kume, T., Akaike, A., Takahashi, R., Shimohama, S. and Sawada, H. (2010) Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells. Biochem. Biophys. Res. Comm. 391, 129-134
47. Qin, Z., Hu, D., Han, S., Reaney, S. H., Di Monte, D. A. and Fink, A. L. (2007) Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. J. Biol. Chem. 282, 5862-5870
48. Giehm, L., Svergun, D. I., Otzen, D. E. and Vestergaard, B. (2011) Low-resolution structure of a vesicle disrupting & alpha;-synuclein oligomer that accumulates during fibrillation. Proc. Natl. Acad. Sci. USA 108, 3246-3251
49. Tsigelny, I. F., Sharikov, Y., Wrasidlo, W., Gonzalez, T., Desplats, P. A., Crews, L., Spencer, B. and Masliah, E. (2012) Role of alpha-synuclein penetration into the membrane in the mechanisms of oligomer pore formation. FEBS J. 279, 1000-1013